Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T12:50:24.421Z.
Calculation as of: 2026-10-06T12:50:24.421Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ac0f7718e38414e938d0d293bbdd3741326646c7ebae4135e2c8e12d98e3a9c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Aktis Oncology, Inc.
Market Cap
$989.05M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Free Cash Flow Yield
N/A
TTM Avg
2.53%
3Y Avg
3.77%
5Y Avg
3.64%
Market Cap
$1.04B
Free Cash Flow Yield
N/A
TTM Avg
17.35%
3Y Avg
119.04%
5Y Avg
59.35%
Market Cap
$1.05B
Free Cash Flow Yield
21.36%
TTM Avg
18.91%
3Y Avg
16.36%
5Y Avg
12.15%
Market Cap
$922.50M
Free Cash Flow Yield
N/A
TTM Avg
16.58%
3Y Avg
25.91%
5Y Avg
25.91%
Market Cap
$921.45M
Free Cash Flow Yield
5.30%
TTM Avg
7.65%
3Y Avg
6.69%
5Y Avg
6.16%
Market Cap
$915.95M
Free Cash Flow Yield
10.29%
TTM Avg
10.89%
3Y Avg
6.48%
5Y Avg
5.13%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | $989.05M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | N/A | N/A | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | N/A | 2.53% | 3.77% | 3.64% |
| CeriBell, Inc. (CBLL)vs › | $943.26M | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.04B | N/A | 17.35% | 119.04% | 59.35% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | 21.36% | 18.91% | 16.36% | 12.15% |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | N/A | 16.58% | 25.91% | 25.91% |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 5.30% | 7.65% | 6.69% | 6.16% |
| Bioventus Inc. (BVS)vs › | $915.95M | 10.29% | 10.89% | 6.48% | 5.13% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
